Author
Joseph A. Baur
- Indexed works
- 26
- Total citations
- 10,663
- Active years
- 13
Collaborators
Works in the record
Nature 2006
Preprint · CC-BY
Resveratrol improves health and survival of mice on a high-calorie diet
The EMBO Journal 2007
Open access · OA
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis
The Journals of Gerontology Series A 2010
Open access · OA
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Journal of Clinical Investigation 2013
Preprint · OA
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Nature 2023
Preprint · OA
CAR T therapy beyond cancer: the evolution of a living drug
PLoS ONE 2011
Open access · CC-BY
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Molecular Metabolism 2021
Open access · CC-BY
Role of NAD+ in regulating cellular and metabolic signaling pathways
Nature Reviews Drug Discovery 2012
Preprint · OA
Are sirtuins viable targets for improving healthspan and lifespan?
Cell Metabolism 2018
Open access · OA
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Scientific Reports 2011
Open access · CC-BY
SRT1720 improves survival and healthspan of obese mice
Redox Biology 2019
Open access · CC-BY
Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice
Mechanisms of Ageing and Development 2010
Citation only
Resveratrol, sirtuins, and the promise of a DR mimetic
Aging 2009
Open access · CC-BY
Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
Annals of the New York Academy of Sciences 2011
Open access · OA
Resveratrol and life extension
Nature Reviews Molecular Cell Biology 2024
Preprint · OA
Regulation of and challenges in targeting NAD+ metabolism
The Journals of Gerontology Series A 2011
Open access · OA
Challenges of Translating Basic Research Into Therapeutics: Resveratrol as an Example
Nature Metabolism 2023
Open access · OA
NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury
Frontiers in Genetics 2012
Open access · CC-BY
Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
Science 2012
Preprint · CC-BY
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Aging 2014
Open access · CC-BY
Rapamycin-induced metabolic defects are reversible in both lean and obese mice
Expert Reviews in Molecular Medicine 2013
Open access · OA
mTOR: more targets of resveratrol?
Endocrine Reviews 2023
Open access · OA
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
JCI Insight 2021
Open access · CC-BY
SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
Aging 2018
Preprint · OA
Aging and drug discovery
The Journals of Gerontology Series A 2023
Open access · CC0
Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop
Cardiovascular Research 2021
Open access · OA